
ootak-agyeya cancer dawa

ootak-rogsoochak cancer davaaen antinoplastic davaaen hain joe cancer kaa ilaaj ootak prakaar key bajaay utparivartan key aadhar parr karati hain joe way pradarshit karate hain. chikitsa upayog key liye anumodit ootak-agyeya aushadhi mein pembrolizumab, larotractinib, selpercatinib, entractinib aur prolsatinib shamil hain.
itihas.
pembrolizumab koo maee 2017 mein americi khaadya aur dawa prashaasan dwara anumodit kiya gayaa thaa.
larotractinib koo navambar, 2018 mein fda dwara anumodit kiya gayaa thaa.
selpercatinib (loxo-292) koo sitambar 2018 mein prathamikta sameeksha praapt hui aur maee 2020 mein sanyukt raajya america mein chikitsa upayog key liye anumodit kiya gayaa thaa.
sanyukt raajya america mein agast 2019 mein, australia mein maee 2020 mein aur europeeya sangh mein julaai 2020 mein chikitsa upayog key liye entratinib koo manjuri dee gaee thee.
prolsatinib koo sitambar 2020 mein sanyukt raajya america mein chikitsa upayog key liye manjuri dee gaee thee.
dabraphenib aur traumatinib koo bee-graph positive thhos tumour key liye ootak-naidaanik davaaon key roop mein anumodit kiya gayaa haye. 
ootak-rogsoochak cancer kii joe davaayen vikasit kii jaa rahee hain unamen salitractinib (loxo-195) aur anty-erbibi3 antibody shamil hain.